fashion -WSS

fashion

author：hotspot 2025-10-01 23:59:30 - browse：9834

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Search warrant issued in 1996 disappearance of Kristin Smart

explore

WSS

JPM pitch from hospitals? Revenue streams outside of patient care

The leaders of Italy and Poland say European Union should focus on stopping migration

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

Medicare Advantage overpayments discussion gets experts fired up

JPM pitch from hospitals? Revenue streams outside of patient care

FDA early review: GLP

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Jerome Adams on the need for new antivirals for Covid

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Medicare details structure of new drug price negotiation program

Ph.D. graduate surprised with gift registry: 'You deserve to be celebrated'

Supreme Court strikes down use of affirmative action

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

At least 13 dead in Texas as scorching temps continue

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

explore

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

Male doctors called my cancer incurable. A female doctor showed it wasn't

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

2 million sign

hotspot

explore

entertainment

Wikipedia